Content Hubs and Community Roundtables
An exclusive opportunity for DIA Community Members.
Content Hubs and Community Round Table Discussions are designed to encourage thought-sharing and collaboration with members of DIA Communities.
Content Hubs
Have 30 minutes? Join in on a conversation and come away with new perspectives!
This non-traditional learning/networking hybrid is specifically designed for small groups to connect with others that share the same interests. Interact with community leaders and have meaningful discussions to gain rapid insight in a subject of value.
Agenda
-
Content Hubs:
Blockchain-Based Technologies for Clinical Research: Distinguishing Myth from Reality
VIEW -
Content Hubs:
How to Get Deep Insights on Treatment Decision Making
VIEW -
Content Hubs:
Risk Management: Box Ticking or Value Add?
VIEW -
Content Hubs:
Speed Networking: Practice Makes Perfect
VIEW
-
Content Hubs:
Networking in Life Sciences is Essential
VIEW -
Content Hubs:
Simultaneous Writing of Clinical Reports, Summaries, and Overview for Submissions: Is this the New Normal?
VIEW -
Content Hubs:
Patients’ Engagement in Drug Development and in Public Private Partnerships
VIEW -
Content Hubs:
RIM Reference Model: An Approach to RIM Data Harmonization and Improving Efficiency, Compliance, and Interoperability
VIEW
-
Content Hubs:
Optimal Uses for Long-Term Patient Councils
VIEW
Community Roundtable Discussions
DIA Community members will host round table discussions inspired by sessions from within the DIA 2023 program agenda. Community Roundtable Discussions are designed to carry learning and debate from sessions to real-life application and discussion. Many of the discussions will include Session Chairs and speakers.
Agenda
-
Roundtable Discussion:
Navigating the Constellation of Efforts to Increase Representation in Clinical Research
VIEW -
Roundtable Discussion:
Risk-Based Monitoring in Clinical Trials: A Four Year Analysis
VIEW -
Roundtable Discussion:
Beyond the Why: How to Effectively Implement a Patient-Led Approach to Clinical Trial Design and Conduct
VIEW
-
Roundtable Discussion:
What's Next in Precision Medicine? Translational Strategies to Dose Optimization in the Age of Project Optimus
VIEW -
Roundtable Discussion:
Ethical Considerations for Conducting Research During Times of Disruption
VIEW -
Roundtable Discussion:
How to Make Good Decisions Quickly
VIEW -
Roundtable Discussion:
Disrupting the Status Quo: Best Practices for Bringing Together Patients and Medical Staff to Positively Impact Trial Diversity
VIEW -
Roundtable Discussion:
Benefit-Risk Balance for Medicinal Products: CIOMS Working Group XII Report
VIEW -
Roundtable Discussion:
A Regulatory Pharmaceutical Quality Knowledge Management System to Improve the Availability of Quality Medicine
VIEW
-
Roundtable Discussion:
IDMP Standards, Structured Submissions, and Data Harmonization Methods: How Will Your Company will be Impacted?
VIEW -
Roundtable Discussion:
Writing Summary Documents for Rare Disease Submissions: Unique Challenges
VIEW -
Roundtable Discussion:
Strategies for Benefit-Risk Analysis in Regulatory Submissions
VIEW -
Roundtable Discussion:
Operationalizing FDA Medical Queries
VIEW -
Roundtable Discussion:
Real-World Data: Maximizing Value and Quality through End-to-End Patient Centricity
VIEW -
Roundtable Discussion:
Crafting the Message: Driving Drug Development Through Compelling Governance Interactions
VIEW